share_log

百本医护(02293)公布中期业绩,股东应占溢利3060万港元 同比减少8.7%

Baiben Healthcare (02293) announced interim results. The profit attributable to shareholders of HK$30.6 million decreased 8.7% year-on-year

Zhitong Finance ·  Feb 23, 2023 21:25

According to the Zhitong Finance App, Baiben Healthcare (02293) announced its interim results announcement for the six months ending December 31, 2022. The company achieved revenue of HK$67.7 million, a decrease of about 7.2% over the previous year; profit attributable to shareholders of HK$30.6 million, a decrease of about 8.7% over the previous year; profit of 7.65 Hong Kong cents per share and an interim dividend of HK$3.75 per common share.

According to the announcement, revenue from providing services related to outreach case assessment fell by about HK$16.6 million to about HK$4.2 million during the period, mainly due to reduced demand for medical and health assessment services (particularly community vaccination centres in Hong Kong, China).

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment